United Therapeutics
UTHR
$270.61
Share price
-0.76%
Change (1 day)
26.22%
Change (1 year)
Categories
United Therapeutics (UTHR) - Total debt
Total debt on the balance sheet as of March 2024 : $0.60 B
According to United Therapeutics's latest financial reports the company's total debt is $0.60 B. A company’s total debt is the sum of all current and non-current debts.
United Therapeutics - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.70 B | -12.5% |
| 2022-12-31 | $0.80 B | 0% |
| 2021-12-31 | $0.80 B | 0% |
| 2020-12-31 | $0.80 B | -5.88% |
| 2019-12-31 | $0.85 B | 240% |
| 2018-12-31 | $0.25 B | 0% |
| 2017-12-31 | $0.25 B | |
| 2015-12-31 | $5.38 M | -95.74% |
| 2014-12-31 | $0.12 B | -55.25% |
| 2013-12-31 | $0.28 B | 2.23% |
| 2012-12-31 | $0.27 B | 4.02% |
| 2011-12-31 | $0.26 B | 12.57% |
| 2010-12-31 | $0.23 B | -5.84% |
| 2009-12-31 | $0.25 B | 6.66% |
| 2008-12-31 | $0.23 B | -6.02% |
| 2007-12-31 | $0.25 B | -0.01% |
| 2006-12-31 | $0.25 B | 1086965.22% |
| 2005-12-31 | $0.02 M | -11.54% |
| 2004-12-31 | $0.02 M | -96.74% |
| 2003-12-31 | $0.79 M | -57.51% |
| 2002-12-31 | $1.87 M | -3.1% |
| 2001-12-31 | $1.93 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 11,707.50% | 🇺🇸 USA |
 Eli Lilly LLY | $26.21 B | 4,268.57% | 🇺🇸 USA |
 Baxter BAX | $14.17 B | 2,261.67% | 🇺🇸 USA |
 Gilead Sciences GILD | $24.98 B | 4,064.50% | 🇺🇸 USA |
 Cardinal Health CAH | $5.85 B | 875.67% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.45 B | 3,643.17% | 🇬🇧 UK |
 Cytokinetics
CYTK | $0.75 B | 25.96% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 3,258.83% | 🇮🇱 Israel |